Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS
· Delayed Price · Currency is USD
0.700
+0.050 (7.68%)
At close: Mar 5, 2026
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 27 employees as of December 31, 2024. The number of employees decreased by 2 or -6.90% compared to the previous year.
Employees
27
Change (1Y)
-2
Growth (1Y)
-6.90%
Revenue / Employee
n/a
Profits / Employee
-$471,565
Market Cap
7.72M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NKGen Biotech | 26 |
| Synlogic | 1 |
| AccuStem Sciences | 2 |
| Mosaic ImmunoEngineering | 8 |
| Bioxytran | 3 |
Brainstorm Cell Therapeutics News
- 8 days ago - Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February - PRNewsWire
- 14 days ago - Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market - PRNewsWire
- 3 months ago - BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 7 months ago - Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 7 months ago - BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - PRNewsWire
- 8 months ago - BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB - PRNewsWire